AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26. Join Globus at booth #361 during OTA for product demonstrations of the PRECICE™ technologies and our full orthopedic trauma product portfolio. Special highlights include our most recent additions to the portfolio including TENSOR™ Suture Button, ANTHEM™ II Dist ...

AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eas ...

Globus Medical, Inc. (GMED) recently reported expansion of its rapidly growing orthopedic trauma product portfolio. The latest launched next-generation systems include ANTHEM II Distal Radius Volar Plates, AUTOBAHN Trochanteric Nail PRO Instruments and CAPTIVATE SOLA Headless Screws. To date, the company has introduced several new system extensions and received the FDA's 510(k) clearance for its TENSOR Suture Button System. The latest addition of these products highlights Globus Medical's continued responsi ...

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estima ...

AUDUBON, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announces the continued growth and expansion of its orthopedic trauma product portfolio. Globus has introduced several new system extensions so far in 2024 and received 510(k) clearance from the U.S. Food and Drug Administration for its first suture-based product, TENSOR™ Suture Button System. Newly launched, next-generation systems include ANTHEM™ II Distal Radius Volar Plates, AU ...

A month has gone by since the last earnings report for Globus Medical (GMED) . Shares have lost about 0.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Globus Medical due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Globus Medical Q2 Earnings Surpass, Raises ...

Globus Medical, Inc. (GMED) is expanding its presence in the musculoskeletal market with cutting-edge solutions, positioning itself for strong growth in the upcoming quarters. Following the NuVasive merger, the companies are working to offer a unique, comprehensive solution that addresses unmet clinical needs and supports surgeons and patients. Though sound financial stability instills optimism, escalating costs and competitive pressures may hurt the company's operations. In the past year, this Zacks Rank # ...

LOS ANGELES, Aug. 23, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE: GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Globus disclosed in an August 13, 2024, SEC filing that, "on July 16, 2024, Glo ...

Globus Medical, Inc. (GMED) recently announced the commercial launch of the ADIRA XLIF Plate System — the first product to be compatible with the company's expanded lateral interbody portfolio. With the latest launch, GMED has achieved a milestone in its integration journey. This should help the company to boost its procedural innovation in lateral spine surgery. About ADIRA XLIF Plate System The ADIRA XLIF Plate System redefines lateral plating by offering simplified insertion workflows and a rigid couplin ...

AUDUBON, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the ADIRA™ XLIF™ Plate System, the Company's first product launch compatible across its expanded lateral interbody portfolio. "This launch represents an important milestone in our integration roadmap," said David Hole, president of Spine at Globus Medical. "Through the system's ability to be paired with our industry-leading Globus and NuVasi ...